Abnormal expression of ADAR1 isoforms in Chinese pediatric acute leukemias

Biochemical and Biophysical Research Communications

Volumn 406, Issue 2, 2011, Pages 245-251

  Ma, Cui Hua ^a   Chong, Jing Hui ^a   Guo, Ye ^b   Zeng, Hui Min ^b   Liu, Shu Yan ^a   Xu, Lin Lin ^a   Wei, Jia ^a   Lin, Yong Min ^a   Zhu, Xiao Fan ^b   Zheng, Guo Guang ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

ADAR1; Expression; Pediatric acute lymphoblastic leukemia; Risk factor; RNA editing

Indexed keywords

ADENOSINE DEAMINASE; ANTINEOPLASTIC AGENT; ISOENZYME; P150 PROTEIN; PROTEIN P100; TYPE 1 ADENOSINE DEAMINASE ACTING ON RNAS 1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR PROMOTION; WESTERN BLOTTING;

ADENOSINE DEAMINASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; HUMANS; ISOENZYMES; LEUKEMIA, MYELOID, ACUTE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REMISSION INDUCTION; RNA EDITING;

EID: 79952449958     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.025     Document Type: Article

References (25)

1. Rice K.L., Hormaeche I., Licht J.D. Epigenetic regulation of normal and malignant hematopoiesis. Oncogene 2007, 26:6697-6714.
2. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002, 71:817-846.
3. Maas S., Rich A., Nishikura K. A-to-I RNA editing: recent news and residual mysteries. J. Biol. Chem. 2003, 278:1391-1394.
4. Valente L., Nishikura K. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog. Nucleic Acid Res. Mol. Biol. 2005, 79:299-338.
5. Morse D.P., Aruscavage P.J., Bass B.L. RNA hairpins in noncoding regions of human brain and Caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA. Proc. Natl. Acad. Sci. USA 2002, 99:7906-7911.
6. Wang Q., Khilan J., Gadue P., Nishikura K. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 2000, 290:1765-1776.
7. Hartner J.C., Schmittwolf C., Kispert A., Müller A.M., Higuchi M., Seeburg P.H. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 2004, 279:4894-4902.
8. Hartner J.C., Walkley C.R., Lu J., Orkin S.H. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 2009, 10:109-115.
9. XuFeng R., Boyer M.J., Shen H., Li Y., Yu H., Gao Y., et al. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc. Natl. Acad. Sci. USA 2009, 106:17763-17768.
10. Yang J.H., Luo X., Nie Y., Su Y., Zhao Q., Kabir K., et al. Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation. Immunology 2003, 109:15-23.
11. Yang J.H., Nie Y., Zhao Q., Su Y., Pypaert M., Su H., et al. Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation. J. Biol. Chem. 2003, 278:45833-45842.
12. Poison A.G., Bass B.L., Casey J.L. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature 1996, 380:454-456.
13. Paz N., Levanon E.Y., Amariglio N., Heimberger A.B., Ram Z., Constantini S., et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 2007, 17:1586-1595.
14. George C.X., Samuel C.E. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc. Natl. Acad. Sci. USA 1999, 96:4621-4626.
15. Strehblow A., Hallegger M., Jantsch M.F. Nucleocytoplasmic distribution of human RNA editing enzyme ADAR1 is modulated by double stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain. Mol. Biol. Cell 2002, 13:3822-3835.
16. Poulsen H., Nilsson J., Damgaard C.K., Egebjerg J., Kjems J. CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. Mol. Cell. Biol. 2001, 21:7862-7871.
17. Mehler M.F. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog. Neurobiol. 2008, 86:305-341.
18. Wang Q., Miyakoda M., Yang W., Khillan J., Stachura D.L., Weiss M.J., Nishikura K. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J. Biol. Chem. 2004, 279:4952-4961.
19. Cenci C., Barzotti R., Galeano F., Corbelli S., Rota R., Massimi L., et al. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J. Biol. Chem. 2008, 283:7251-7260.
20. Beghini A., Ripamonti C.B., Peterlongo P., Roversi G., Cairoli R., Morra E., et al. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum. Mol. Genet. 2000, 9:2297-2304.
21. Chong J.H., Zheng G.G., Zhu X.F., Guo Y., Wang L., Ma C.H., et al. Abnormal expression of P2X family receptors in Chinese pediatric acute leukemias. Biochem. Biophys. Res. Commun. 2010, 391:498-504.
22. Tendier C.L., Burton J.D., Jatte J., Danielpour D., Charley M., McCoy J.P., et al. Abnormal cytokine expression in Sézary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies. Cancer Res. 1994, 54:4430-4435.
23. Pui C.H., Robison L.L., Look A.T. Acute lymphoblastic leukaemia. Lancet 2008, 371:1030-1043.
24. Hafiz M.G., Rahman M.M., Mannan M.A. Serum lactate dehydrogenase as prognostic marker of childhood acute lymphoblastic leukemia. Mymensingh. Med. J. 2008, 17:169-173.
25. Wang Y., Samuel C.E. Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2α phosphorylation. J. Mol. Biol. 2009, 393:777-787.